Registry of overweight and obese adults with type 1 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study establishes a registry of adult patients with type 1 diabetes who visit the Department of Endocrinology at the University Hospitals of Leuven. The aim is to phenotype these patients, focusing on their obesity and treatment responses. Data collected will include sociodemographics, medical history, glycemic control, comorbidities, clinical and anthropometric parameters, and lifestyle factors. This comprehensive database will help in understanding the impact of obesity on type 1 diabetes outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Signed informed consent
* Type 1 Diabetes

Where it's running

• Departement Endocrinology, University Hospitals Leuven
  Leuven, Belgium Recruiting

Study contacts

• Study coordinator: Bart Van der Schueren, MD, PhD
• Email: bart.vanderschueren@uzleuven.be
• Phone: +3216346994

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exploring the gut microbiome's role in type 1 diabetes and metformin's effects

  This study is testing how the gut bacteria of obese teens with type 1 diabetes affects their condition and whether the diabetes drug metformin can help improve their health.

  Recruiting Phase 2 Indiana University · Indianapolis, Indiana · NCT05414409

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

• Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists

  This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.

  Recruiting at 9 sites Phase 1 Amgen · Phoenix, Arizona and 8 other locations · NCT07908316

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.